Buntyn RW et al. |
Inhibition of Endocannabinoid-Metabolizing Enzymes in Peripheral Tissues Following Developmental Chlorpyrifos Exposure in Rats. |
|
Int. J. Toxicol. |
pmid:28820005
|
|
|
|
|
pmid:
|
Lee M et al. |
Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes. |
1995 |
J. Pharmacol. Exp. Ther. |
pmid:7473135
|
Sugiura T et al. |
2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. |
1995 |
Biochem. Biophys. Res. Commun. |
pmid:7575630
|
Mechoulam R et al. |
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. |
1995 |
Biochem. Pharmacol. |
pmid:7605349
|
Di Marzo V et al. |
Potential biosynthetic connections between the two cannabimimetic eicosanoids, anandamide and 2-arachidonoyl-glycerol, in mouse neuroblastoma cells. |
1996 |
Biochem. Biophys. Res. Commun. |
pmid:8858137
|
Sugiura T et al. |
2-Arachidonoylglycerol, a putative endogenous cannabinoid receptor ligand, induces rapid, transient elevation of intracellular free Ca2+ in neuroblastoma x glioma hybrid NG108-15 cells. |
1996 |
Biochem. Biophys. Res. Commun. |
pmid:8954083
|
Sugiura T et al. |
Inhibition by 2-arachidonoylglycerol, a novel type of possible neuromodulator, of the depolarization-induced increase in intracellular free calcium in neuroblastoma x glioma hybrid NG108-15 cells. |
1997 |
Biochem. Biophys. Res. Commun. |
pmid:9144424
|
Bisogno T et al. |
Biosynthesis of 2-arachidonoyl-glycerol, a novel cannabimimetic eicosanoid, in mouse neuroblastoma cells. |
1997 |
Adv. Exp. Med. Biol. |
pmid:9561135
|
Bisogno T et al. |
Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells. |
1997 |
Biochem. J. |
pmid:9065792
|
Stella N et al. |
A second endogenous cannabinoid that modulates long-term potentiation. |
1997 |
Nature |
pmid:9285589
|
Gurwitz D and Kloog Y |
Do endogenous cannabinoids contribute to HIV-mediated immune failure? |
1998 |
Mol Med Today |
pmid:9612798
|
Mechoulam R et al. |
Endocannabinoids. |
1998 |
Eur. J. Pharmacol. |
pmid:9831287
|
Piomelli D et al. |
Endogenous cannabinoid signaling. |
1998 |
Neurobiol. Dis. |
pmid:9974178
|
Barnett-Norris J et al. |
Exploration of biologically relevant conformations of anandamide, 2-arachidonylglycerol, and their analogues using conformational memories. |
1998 |
J. Med. Chem. |
pmid:9822555
|
Ouyang Y et al. |
Suppression of interleukin-2 by the putative endogenous cannabinoid 2-arachidonyl-glycerol is mediated through down-regulation of the nuclear factor of activated T cells. |
1998 |
Mol. Pharmacol. |
pmid:9547358
|
Di Marzo V |
2-Arachidonoyl-glycerol as an "endocannabinoid": limelight for a formerly neglected metabolite. |
1998 |
Biochemistry Mosc. |
pmid:9526090
|
Sugiura T et al. |
Detection of an endogenous cannabimimetic molecule, 2-arachidonoylglycerol, and cannabinoid CB1 receptor mRNA in human vascular cells: is 2-arachidonoylglycerol a possible vasomodulator? |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9501013
|
Di Marzo V et al. |
Trick or treat from food endocannabinoids? |
1998 |
Nature |
pmid:9872309
|
Kondo S et al. |
2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist: identification as one of the major species of monoacylglycerols in various rat tissues, and evidence for its generation through CA2+-dependent and -independent mechanisms. |
1998 |
FEBS Lett. |
pmid:9650580
|
Ben-Shabat S et al. |
An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. |
1998 |
Eur. J. Pharmacol. |
pmid:9721036
|
Mechoulam R et al. |
Carbachol, an acetylcholine receptor agonist, enhances production in rat aorta of 2-arachidonoyl glycerol, a hypotensive endocannabinoid. |
1998 |
Eur. J. Pharmacol. |
pmid:9865537
|
Di Marzo V et al. |
The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide. |
1998 |
Biochem. J. |
pmid:9512456
|
Goparaju SK et al. |
Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand. |
1998 |
FEBS Lett. |
pmid:9475172
|
Paria BC et al. |
Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors. |
1998 |
Biol. Reprod. |
pmid:9623610
|
Piomelli D et al. |
Structural determinants for recognition and translocation by the anandamide transporter. |
1999 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:10318965
|
Di Marzo V et al. |
Metabolism of anandamide and 2-arachidonoylglycerol: an historical overview and some recent developments. |
1999 |
Lipids |
pmid:10419192
|
Self DW |
Anandamide: a candidate neurotransmitter heads for the big leagues. |
1999 |
Nat. Neurosci. |
pmid:10204533
|
Giuffrida A et al. |
Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. |
1999 |
Nat. Neurosci. |
pmid:10204543
|
Bisogno T et al. |
Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function. |
1999 |
Biochem. Biophys. Res. Commun. |
pmid:10079192
|
Martin BR et al. |
Discovery and characterization of endogenous cannabinoids. |
1999 |
Life Sci. |
pmid:10462059
|
Di Marzo V |
Biosynthesis and inactivation of endocannabinoids: relevance to their proposed role as neuromodulators. |
1999 |
Life Sci. |
pmid:10462065
|
Wagner JA et al. |
Mesenteric vasodilation mediated by endothelial anandamide receptors. |
1999 |
Hypertension |
pmid:9931142
|
Goparaju SK et al. |
Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors. |
1999 |
Biochem. Pharmacol. |
pmid:9933030
|
Bisogno T et al. |
Phosphatidic acid as the biosynthetic precursor of the endocannabinoid 2-arachidonoylglycerol in intact mouse neuroblastoma cells stimulated with ionomycin. |
1999 |
J. Neurochem. |
pmid:10217292
|
Sugiura T et al. |
[2-Arachidonoylglycerol: an endogenous cannabinoid receptor agonist]. |
1999 |
Tanpakushitsu Kakusan Koso |
pmid:10396990
|
Di Marzo V et al. |
Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages. |
1999 |
Eur. J. Biochem. |
pmid:10447696
|
Bisogno T et al. |
Biosynthesis and inactivation of N-arachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamine in bovine retina. |
1999 |
Arch. Biochem. Biophys. |
pmid:10577359
|
Huang SM et al. |
Liquid chromatographic-mass spectrometric measurement of the endogenous cannabinoid 2-arachidonylglycerol in the spinal cord and peripheral nervous system. |
1999 |
Zhongguo Yao Li Xue Bao |
pmid:11189199
|
Sugiura T and Waku K |
2-arachidonoylglycerol: a possible multifunctional lipid mediator in the nervous and immune systems. |
2000 |
Ann. N. Y. Acad. Sci. |
pmid:10818479
|
Sinor AD et al. |
Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats. |
2000 |
Neurosci. Lett. |
pmid:10653017
|
Sugiura T et al. |
Generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in picrotoxinin-administered rat brain. |
2000 |
Biochem. Biophys. Res. Commun. |
pmid:10814517
|
Basavarajappa BS et al. |
Stimulation of cannabinoid receptor agonist 2-arachidonylglycerol by chronic ethanol and its modulation by specific neuromodulators in cerebellar granule neurons. |
2000 |
Biochim. Biophys. Acta |
pmid:11113634
|
Pryor SR |
Is platelet release of 2-arachidonoyl-glycerol a mediator of cognitive deficits? An endocannabinoid theory of schizophrenia and arousal. |
2000 |
Med. Hypotheses |
pmid:11090297
|
Rhee MH et al. |
Functional role of tryptophan residues in the fourth transmembrane domain of the CB(2) cannabinoid receptor. |
2000 |
J. Neurochem. |
pmid:11080201
|
Sugiura T and Waku K |
2-Arachidonoylglycerol and the cannabinoid receptors. |
2000 |
Chem. Phys. Lipids |
pmid:11106784
|
Gallily R et al. |
2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-alpha production in murine macrophages, and in mice. |
2000 |
Eur. J. Pharmacol. |
pmid:11011050
|
Chen Y et al. |
Human brain capillary endothelium: 2-arachidonoglycerol (endocannabinoid) interacts with endothelin-1. |
2000 |
Circ. Res. |
pmid:10948067
|
Suhara Y et al. |
Synthesis and biological activities of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, and its metabolically stable ether-linked analogues. |
2000 |
Chem. Pharm. Bull. |
pmid:10923815
|
Járai Z et al. |
Cardiovascular effects of 2-arachidonoyl glycerol in anesthetized mice. |
2000 |
Hypertension |
pmid:10679517
|
Kozak KR et al. |
Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2. |
2000 |
J. Biol. Chem. |
pmid:10931854
|
Ameri A and Simmet T |
Effects of 2-arachidonylglycerol, an endogenous cannabinoid, on neuronal activity in rat hippocampal slices. |
2000 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:10731038
|
Melck D et al. |
Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. |
2000 |
Endocrinology |
pmid:10614630
|
Sugiura T et al. |
Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells. |
2000 |
J. Biol. Chem. |
pmid:10617657
|
Jarrahian A et al. |
Structure-activity relationships among N-arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter. |
2000 |
J. Neurochem. |
pmid:10820223
|
Gonsiorek W et al. |
Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide. |
2000 |
Mol. Pharmacol. |
pmid:10779390
|
Hillard CJ |
Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol. |
2000 |
Prostaglandins Other Lipid Mediat. |
pmid:10785538
|
Di Marzo V et al. |
Cannabimimetic fatty acid derivatives in cancer and inflammation. |
2000 |
Prostaglandins Other Lipid Mediat. |
pmid:10785541
|
Kunos G et al. |
Cardiovascular effects of endocannabinoids--the plot thickens. |
2000 |
Prostaglandins Other Lipid Mediat. |
pmid:10785543
|
Beltramo M and Piomelli D |
Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol. |
2000 |
Neuroreport |
pmid:10817598
|
Maccarrone M et al. |
Anandamide and 2-arachidonoylglycerol inhibit fatty acid amide hydrolase by activating the lipoxygenase pathway of the arachidonate cascade. |
2000 |
Biochem. Biophys. Res. Commun. |
pmid:11095952
|
Calignano A et al. |
A role for the endogenous cannabinoid system in the peripheral control of pain initiation. |
2000 |
Prog. Brain Res. |
pmid:11098711
|
Di Marzo V et al. |
Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain. |
2000 |
J. Neurochem. |
pmid:11080195
|
Howlett AC and Mukhopadhyay S |
Cellular signal transduction by anandamide and 2-arachidonoylglycerol. |
2000 |
Chem. Phys. Lipids |
pmid:11106782
|
Stefano GB et al. |
2-arachidonyl-glycerol stimulates nitric oxide release from human immune and vascular tissues and invertebrate immunocytes by cannabinoid receptor 1. |
2000 |
Pharmacol. Res. |
pmid:10987990
|
Martin BR et al. |
Cannabinoid properties of methylfluorophosphonate analogs. |
2000 |
J. Pharmacol. Exp. Ther. |
pmid:10945879
|
Hillard CJ |
Endocannabinoids and vascular function. |
2000 |
J. Pharmacol. Exp. Ther. |
pmid:10871291
|
Schmid PC et al. |
A sensitive endocannabinoid assay. The simultaneous analysis of N-acylethanolamines and 2-monoacylglycerols. |
2000 |
Chem. Phys. Lipids |
pmid:10669310
|
Di Marzo V et al. |
Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide. |
2000 |
Eur. J. Pharmacol. |
pmid:11040343
|
Szallasi A and Di Marzo V |
New perspectives on enigmatic vanilloid receptors. |
2000 |
Trends Neurosci. |
pmid:11006466
|
González S et al. |
Sex steroid influence on cannabinoid CB(1) receptor mRNA and endocannabinoid levels in the anterior pituitary gland. |
2000 |
Biochem. Biophys. Res. Commun. |
pmid:10733937
|
Di Marzo V et al. |
Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease. |
2000 |
FASEB J. |
pmid:10877836
|
Fowler CJ et al. |
Fatty acid amide hydrolase: biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleamide. |
2001 |
Biochem. Pharmacol. |
pmid:11585048
|
Moody JS et al. |
Selective oxygenation of the endocannabinoid 2-arachidonylglycerol by leukocyte-type 12-lipoxygenase. |
2001 |
Biochemistry |
pmid:11170406
|
Sugiura T and Waku K |
2-arachidonoylglycerol: an endogenous cannabinoid receptor agonist. |
2001 |
World Rev Nutr Diet |
pmid:11935957
|
Baker D et al. |
Endocannabinoids control spasticity in a multiple sclerosis model. |
2001 |
FASEB J. |
pmid:11156943
|
MacCarrone M et al. |
Human platelets bind and degrade 2-arachidonoylglycerol, which activates these cells through a cannabinoid receptor. |
2001 |
Eur. J. Biochem. |
pmid:11168423
|
Kurihara J et al. |
2-Arachidonoylglycerol and anandamide oppositely modulate norepinephrine release from the rat heart sympathetic nerves. |
2001 |
Jpn. J. Pharmacol. |
pmid:11676206
|
van der Stelt M et al. |
Exogenous anandamide protects rat brain against acute neuronal injury in vivo. |
2001 |
J. Neurosci. |
pmid:11698588
|
Hansen HH et al. |
Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration. |
2001 |
J. Neurochem. |
pmid:11579150
|
Stella N and Piomelli D |
Receptor-dependent formation of endogenous cannabinoids in cortical neurons. |
2001 |
Eur. J. Pharmacol. |
pmid:11513837
|
Maccarrone M et al. |
Anandamide degradation and N-acylethanolamines level in wild-type and CB1 cannabinoid receptor knockout mice of different ages. |
2001 |
J. Neurochem. |
pmid:11461969
|
Al-Hayani A et al. |
The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice. |
2001 |
Neuropharmacology |
pmid:11747904
|
Wagner JA et al. |
Endogenous cannabinoids mediate hypotension after experimental myocardial infarction. |
2001 |
J. Am. Coll. Cardiol. |
pmid:11738314
|
Kagota S et al. |
2-Arachidonoylglycerol, a candidate of endothelium-derived hyperpolarizing factor. |
2001 |
Eur. J. Pharmacol. |
pmid:11275004
|
Bisogno T et al. |
The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors. |
2001 |
Eur. J. Biochem. |
pmid:11277920
|
Kobayashi Y et al. |
Activation by 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, of p42/44 mitogen-activated protein kinase in HL-60 cells. |
2001 |
J. Biochem. |
pmid:11328586
|
Kozak KR et al. |
Amino acid determinants in cyclooxygenase-2 oxygenation of the endocannabinoid 2-arachidonylglycerol. |
2001 |
J. Biol. Chem. |
pmid:11402053
|
Di Marzo V et al. |
Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells. |
2001 |
Biochem. J. |
pmid:11485574
|
Sugiura T et al. |
Rapid generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in rat brain after decapitation. |
2001 |
Neurosci. Lett. |
pmid:11137756
|
Wang Y et al. |
Simultaneous measurement of anandamide and 2-arachidonoylglycerol by polymyxin B-selective adsorption and subsequent high-performance liquid chromatography analysis: increase in endogenous cannabinoids in the sera of patients with endotoxic shock. |
2001 |
Anal. Biochem. |
pmid:11412008
|
Maccarrone M et al. |
Gas chromatography-mass spectrometry analysis of endogenous cannabinoids in healthy and tumoral human brain and human cells in culture. |
2001 |
J. Neurochem. |
pmid:11208922
|
Panikashvili D et al. |
An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. |
2001 |
Nature |
pmid:11586361
|
Savinainen JR et al. |
Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB(1) receptor-dependent G-protein activation in rat cerebellar membranes. |
2001 |
Br. J. Pharmacol. |
pmid:11588122
|
Suhara Y et al. |
Synthesis and biological activities of novel structural analogues of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. |
2001 |
Bioorg. Med. Chem. Lett. |
pmid:11454463
|
Yamaguchi T et al. |
Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice. |
2001 |
Brain Res. |
pmid:11478928
|
Di Marzo V et al. |
Leptin-regulated endocannabinoids are involved in maintaining food intake. |
2001 |
Nature |
pmid:11298451
|
Wilson RI and Nicoll RA |
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. |
2001 |
Nature |
pmid:11279497
|
Giuffrida A et al. |
Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology. |
2001 |
J. Pharmacol. Exp. Ther. |
pmid:11408519
|
Berdyshev EV et al. |
Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells. |
2001 |
FASEB J. |
pmid:11641243
|